thalidomide has been researched along with sphingosine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Angelini, A; Carraro, U; Ceconi, C; Dalla Libera, L; Ravara, B; Sandri, M; Vescovo, G | 1 |
| Igarashi, Y; Okazaki, T; Taguchi, Y; Tomimoto, H; Yabu, T; Yamaoka, S | 1 |
3 other study(ies) available for thalidomide and sphingosine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Effect of thalidomide on the skeletal muscle in experimental heart failure.
Topics: Animals; Apoptosis; Heart Failure; Monocrotaline; Muscle, Skeletal; Muscular Atrophy; Myosin Heavy Chains; Rats; Rats, Sprague-Dawley; Sphingosine; Thalidomide; Tumor Necrosis Factor-alpha; Ventricular Dysfunction, Right | 2002 |
Thalidomide-induced antiangiogenic action is mediated by ceramide through depletion of VEGF receptors, and is antagonized by sphingosine-1-phosphate.
Topics: Angiogenesis Inhibitors; Animals; DNA, Complementary; Embryo, Nonmammalian; Endothelium, Vascular; Eye Abnormalities; Humans; Lysophospholipids; Magnesium; Neuropilin-1; Oligonucleotides, Antisense; Sphingomyelin Phosphodiesterase; Sphingosine; Thalidomide; Umbilical Veins; Vascular Endothelial Growth Factor Receptor-2; Zebrafish | 2005 |